Analysis reveals elemental variations in Kalanchoe laetivirens extracts, highlighting health risks and regulatory implications.
Kalanchoe laetivirens is widely consumed as a medicinal plant in rural and urban communities, traditionally used in folk medicine for treating inflammatory conditions and cancer. However, little is known about its elemental composition and the potential health risks associated with different preparation methods. This study aimed to evaluate concentrations of Al, As, Ba, Co, Cu, Fe, Mg, Mn, Mo, Na, Ni, P, Pb, Se, V, and Zn in raw leaves, tea infusions, and aqueous extracts, and to assess associated health risks. Elemental analysis revealed significant differences among preparations, with raw leaves presenting the highest concentrations, tea showing intermediate values, and aqueous extracts the lowest. For example, potassium (K) reached 15,399.31 ± 131.55 mg/kg in leaves and 12,249.97 ± 240.17 mg/L in tea, while arsenic (As) and lead (Pb) were also detected at concerning levels, with As at 5.98 ± 1.64 mg/L and Pb at 3.82 ± 0.179 mg/L in tea. Risk assessment was performed using the Chronic Daily Intake (CDI), Hazard Quotients (HQs), Hazard Index (HI), and Incremental Lifetime Cancer Risk (ILCR), considering different exposure frequencies. Results indicated phosphorus (P) as the dominant contributor to non-carcinogenic risk, with HI values exceeding safety thresholds in all scenarios, while arsenic was the primary carcinogenic element, with ILCR values up to 10−3 in tea. These findings highlight the influence of preparation methods on exposure levels and reinforce the need for continuous monitoring and regulatory guidelines to ensure the safe medicinal use of K. laetivirens.
No takes yet. Share an insight, caveat, or question.
Siqueira et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: